Cariprazine for bipolar depression in ages 10 to 17
Treatments studied
Part of Mental health clinical trials.
This Phase 3 study tests whether cariprazine can improve depression symptoms in children and teens with bipolar I disorder, and also tracks side effects. It may help if your depressive episode is ongoing and you meet specific mood and screening score requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Ages 10 to 17 with bipolar I disorder diagnosed by a structured interview
- You have a depressive episode that lasts more than 2 weeks but less than 12 months
- You have had at least one past manic episode
- Your depression and mood ratings are within specific ranges at two visits
- Your doctor rates you as at least “moderately ill” at two visits
- You must not have certain other conditions (like schizophrenia or PTSD) or key medical risks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a monthly injection of cariprazine (a medication for mental health conditions) in people who could benefit from it. It aims to see if the shot is safe, tolerable, and effective compared to taking pills every day.
This trial is testing treatments for children and teens (ages 9–19) who have been diagnosed with bipolar disorder or cyclothymic disorder. It also requires regular participation from a caregiver so the team can track symptoms and response over time.
This study tests an oral medication called icalcaprant for adults with bipolar I or II who are currently in a depressive episode. The goal is to see if it reduces symptoms and whether it's safe when taken alongside your usual mood stabilizer.
This trial tests a step-by-step approach to treating moderate-to-severe depression in teens. It may help find a treatment path that improves mood while keeping care safe, including for some teens who have suicidal thoughts but do not need inpatient care.
This trial tests whether cariprazine works and is safe for teens aged 13 to 17 with schizophrenia. It may help if your symptoms are still moderate to severe despite current care.
This Phase 4 trial tests how well cariprazine works by itself to reduce symptoms of major depressive disorder (MDD). You may be eligible if you’re currently in a depressive episode and your depression score stays within a certain range at both screening and study start.
Hear when a new Depression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.